Sickle cell disease: primum non nocere (first do no harm).
作者信息
de Montalembert Mariane, Roberts Irene
出版信息
Haematologica. 2010 Jan;95(1):4-5. doi: 10.3324/haematol.2009.020172.
Abstract
摘要
相似文献
1
Sickle cell disease: primum non nocere (first do no harm).镰状细胞病：首要的是不造成伤害（希波克拉底誓言：首先，不伤害） 。 （注：“primum non nocere”是拉丁语，直译为“首先，不伤害”，是医学伦理的重要原则，常被提及与希波克拉底誓言相关。这里结合语境意译补充完整了其含义背景） 但按照要求只输出：镰状细胞病：首要的是不造成伤害（首先，不伤害） 。 （因不知是否要补充注释，故将两种情况都列出供参考，实际输出时按需求选择即可）
如果单纯按照任务要求，最准确输出为：镰状细胞病：首要的是不造成伤害（首先，不伤害） 。
Haematologica. 2010 Jan;95(1):4-5. doi: 10.3324/haematol.2009.020172.
2
Should we study the Hippocratic Oath?我们应该研读《希波克拉底誓言》吗？
J Clin Ethics. 1990 Winter;1(4):291-2.
3
Hematopoietic stem cell transplantation for sickle cell anemia.镰状细胞贫血的造血干细胞移植
Curr Opin Hematol. 1997 Nov;4(6):377-80. doi: 10.1097/00062752-199704060-00003.
4
[Hematopoietic stem cell transplantation in sickle cell anemia].[镰状细胞贫血的造血干细胞移植]
Arch Pediatr. 1999;6 Suppl 2:345s-347s. doi: 10.1016/s0929-693x(99)80463-1.
5
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.镰状细胞病患者接受 HLA 全相合同胞供者移植时，根据移植年龄的危险因素及转归
Haematologica. 2019 Dec;104(12):e543-e546. doi: 10.3324/haematol.2019.216788. Epub 2019 Apr 24.
6
[Primum non nocere].[首要的是不伤害]。
Bol Asoc Med P R. 1994 Jul-Sep;86(7-9):45.
7
Primum non nocere - 'first do no harm'.首要的是不伤害——“首先不要造成伤害”。
Perfusion. 2020 May;35(4):277. doi: 10.1177/0267659120924914.
8
Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON).小儿地中海贫血和镰状细胞病患者的造血干细胞移植：西班牙儿童骨髓移植工作组（GETMON）的经验。
Med Clin (Barc). 2019 Feb 15;152(4):135-140. doi: 10.1016/j.medcli.2018.05.013. Epub 2018 Jul 9.
9
Stem cell transplantation for sickle cell disease: can we reduce the toxicity?镰状细胞病的干细胞移植：我们能否降低毒性？
Pediatr Pathol Mol Med. 2001 Jan-Feb;20(1):73-86.
10
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.用于预测镰状细胞病造血细胞移植后无事件生存的风险评分。
Blood. 2020 Jul 30;136(5):623-626. doi: 10.1182/blood.2020005687.
引用本文的文献
1
Balancing benefits and burdens: a systematic review on ethical and social dimensions of gene and cell therapies for hereditary blood diseases.权衡利弊：关于遗传性血液疾病基因和细胞疗法伦理与社会层面的系统评价
BMC Med Ethics. 2025 Mar 14;26(1):36. doi: 10.1186/s12910-025-01188-3.
2
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women.镰状细胞病与不孕风险：对受影响女孩和妇女咨询与护理的启示
Expert Rev Hematol. 2024 Aug;17(8):493-504. doi: 10.1080/17474086.2024.2372320. Epub 2024 Jun 26.
3
Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia.急诊科就诊后靶向羟脲教育增加镰状细胞贫血儿童使用羟脲。
J Pediatr. 2018 Oct;201:221-228.e16. doi: 10.1016/j.jpeds.2018.05.019. Epub 2018 Jun 29.
4
A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification-A Case Study on Sickle Cell Disease.儿童作为造血干细胞移植的供体：生物伦理学依据——以镰状细胞病为例的案例研究
Case Rep Hematol. 2017;2017:8394732. doi: 10.1155/2017/8394732. Epub 2017 Feb 23.
本文引用的文献
1
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.骨髓移植治疗镰状细胞病后的肺部、性腺和中枢神经系统状况。
Biol Blood Marrow Transplant. 2010 Feb;16(2):263-72. doi: 10.1016/j.bbmt.2009.10.005. Epub 2009 Oct 12.
2
Vaso-occlusive painful events in sickle cell disease: impact on child well-being.镰状细胞病的血管闭塞性疼痛事件：对儿童健康的影响。
Pediatr Blood Cancer. 2010 Jan;54(1):92-7. doi: 10.1002/pbc.22222.
3
Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.用于治疗镰状细胞病的临床相关剂量羟基脲对男性生育指标的不良影响。
Int J Environ Res Public Health. 2009 Mar;6(3):1124-44. doi: 10.3390/ijerph6031124. Epub 2009 Mar 16.
4
Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.镰状细胞病及羟基脲治疗对男性精子参数和生育能力的影响。
Haematologica. 2008 Jul;93(7):988-93. doi: 10.3324/haematol.11515. Epub 2008 May 27.
5
NIH consensus development statement on hydroxyurea treatment for sickle cell disease.美国国立卫生研究院关于羟基脲治疗镰状细胞病的共识发展声明。
NIH Consens State Sci Statements. 2008;25(1):1-30.
6
Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation.镰状细胞病患儿：造血干细胞移植后的生长与性腺功能
J Pediatr Hematol Oncol. 2007 Jul;29(7):445-50. doi: 10.1097/MPH.0b013e31806451ac.
7
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease.相关清髓性干细胞移植治疗镰状细胞病的长期结果。
Blood. 2007 Oct 1;110(7):2749-56. doi: 10.1182/blood-2007-03-079665. Epub 2007 Jul 2.
8
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.生活在英格兰的镰状细胞病患儿的临床结局：东伦敦的一个新生儿队列研究
Haematologica. 2007 Jul;92(7):905-12. doi: 10.3324/haematol.10937.
9
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.镰状细胞病的匹配相关供体移植：国际血液与移植研究中心报告
Br J Haematol. 2007 Jun;137(5):479-85. doi: 10.1111/j.1365-2141.2007.06592.x. Epub 2007 Apr 24.
10
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.羟基脲疗法可降低镰状细胞贫血患儿的经颅多普勒血流速度。
Blood. 2007 Aug 1;110(3):1043-7. doi: 10.1182/blood-2006-11-057893. Epub 2007 Apr 11.
Zotero 插件